What is Microbial Limit Testing?

Microbial Limit Testing evaluates the bioburden (microbial load) of pharmaceutical products such as tablets, syrups, ointments, and creams. It checks for both:

Quantitative limits – total number of viable microorganisms (bacteria, yeast, and mold)
Qualitative limits – absence of specified pathogenic microorganisms (e.g., Escherichia coli, Salmonella, Staphylococcus aureus)

Governing Pharmacopoeial Standards

Pharmacopoeia	Chapter
USP (United States)	<61> & <62>
EP (European)	2.6.12 & 2.6.13
BP (British)	Appendix XVI
IP (Indian)	Appendix 8.2

Commonly Tested Microorganisms

Escherichia coli – indicator of fecal contamination
Staphylococcus aureus – common skin pathogen
Pseudomonas aeruginosa – opportunistic pathogen in aqueous products
Salmonella spp. – enteric pathogens
Candida albicans – fungal contamination
Clostridium spp. – anaerobic spore-formers
Burkholderia cepacia complex – for water-based products (linked with USP <60>

<60>

Acceptance Criteria as per USP

Product Type	TAMC (CFU/g or mL)	TYMC (CFU/g or mL)	Specified Microorganisms
Oral preparations	Not more than 103	Not more than 102	Absence of E. coli
Topical products	Not more than 102	Not more than 101	Absence of P. aeruginosa, S. aureus, C. albicans
Rectal/vaginal preparations	Not more than 102	Not more than 101	Absence of P. aeruginosa, S. aureus, C. albicans

sss

1. Oral Preparations

These are products taken by mouth and swallowed. They pass through the gastrointestinal (GI) tract.

Examples: Tablets, capsules, oral liquids (syrups, suspensions), and powders.
Microbial Allowances: Because the stomach contains harsh acids that naturally kill many bacteria, the limits here are slightly higher ( $10^3$ for TAMC and $10^2$ for TYMC) compared to other routes.
Specified Exclusion: Absence of E. coli. Since E. coli is a fecal contaminant that causes severe gastrointestinal illness, it must be completely absent.

2. Topical Products

These are products applied directly to external body surfaces like the skin or mucous membranes.

Examples: Creams, ointments, gels, lotions, and transdermal patches.
Microbial Allowances: Skin can be broken, scraped, or compromised, making it easier for infections to take hold. Therefore, the limits are stricter ( $10^2$ for TAMC and $10^1$ for TYMC).
Specified Exclusions: * P. aeruginosa: A bacteria that thrives in moist environments and causes severe skin/wound infections.
- S. aureus: Common cause of skin infections like boils and cellulitis.
- C. albicans: A yeast that can cause fungal skin or diaper rash infections.

3. Rectal / Vaginal Preparations

These are products designed to be inserted into the rectum or vagina for either local treatment or systemic absorption.

Examples: Suppositories, vaginal tablets, enemas, and specialized creams or gels.
Microbial Allowances: These mucosal membranes are highly sensitive, vascular (rich in blood vessels), and easily irritated. Like topical products, they require strict limits ( $10^2$ for TAMC and $10^1$ for TYMC).
Specified Exclusions: Absence of P. aeruginosa, S. aureus, and C. albicans for the same reasons as topical products—these areas are highly susceptible to yeast infections (Candida) and bacterial vaginosis or irritation.

1. Standard Sampling Rule

Product Type	Sample Size	Example
Solid/liquid (bulk)	10 g or 10 mL	10 g of herbal powder, 10 mL of syrup
Aerosol (fluid/solid)	10 containers	10 nasal spray bottles, 10 inhaler canisters
Transdermal patches	10 patches	10 nicotine patches
Orodispersible films	10 films	10 oral rapidly-dissolving films

2. Low-Dose Active Substance Reduction 📉

Condition: Amount per dosage unit ≤ 1 mg OR amount per g/mL < 1 mg

Scenario	Standard Rule	Reduced Sample	Example
Tablet/capsule	10 g bulk	Amount in 10 tablets	Folic acid tablet (0.4 mg active): Test 10 tablets (4 mg total) instead of 10 g bulk
Injection	10 mL bulk	Amount in 10 vials	Vitamin B12 injection (0.5 mg/mL): Test 10 vials (5 mg total)
Bulk powder	10 g	Amount in 10 g	Thyroxine powder (0.05 mg/g): Test minimum 10 g (contains 0.5 mg active)

Why reduce? Testing 10 g of low-dose product would dilute the active too much for accurate microbial detection.

3. Very Small Batch (<1000 g or mL) 🧪

Rule: Test 1% of batch size (unless lesser amount is justified)

Batch Size	Sample to Test	Example
500 g powder	5 g (1%)	Clinical trial batch of 500 g herbal extract → test 5 g
200 mL liquid	2 mL (1%)	Small-batch serum (200 mL) → test 2 mL
800 g ointment	8 g (1%)	Compounded ointment (800 g batch) → test 8 g

4. Very Small Entity Count (Clinical Trials) 🔬

Total Entities in Batch	Sample Size	Example
< 200 units	2 units	Clinical trial batch of 150 tablets → test 2 tablets
< 100 units	1 unit	Pilot batch of 80 vials → test 1 vial

Sample Size Determination Matrix

Product / Batch Scenario	Minimum Required Sample Size	Special Instructions / Notes
Standard Product (Fluid or Solid)	10 g or 10 mL	Standard default requirement.
Aerosols (Fluids or Solids)	10 containers	Blend or pool to obtain the test specimen.
Low-Dose Products ( $\le 1\text{ mg}$ per unit or per g/mL)	Amount in 10 dosage units (or 10 g / 10 mL of product)	Applies to highly potent active substances or micro-dose formulations.
Small Batches / Limited Material (Total batch size less than 1000 g or 1000 mL)	1% of the total batch	A lesser amount can only be used if scientifically justified and authorized.
Clinical Trials / Very Small Batches (Total batch size less than 200 units)	2 units	Reduce to 1 unit if the total batch size is less than 100 units.

Why 10g/10mL is weighing for MLT analysis (Raw material)?

Minimum requirement: • Every batch size has been calculated based on the required concentration of active substances. • As per guideline (USP 61, 62), the amount of raw material tested shall be 1% of the total active substances for extremely small batch (less than 1000 g or 1000 mL). • For example, if the batch size is 1000 g, the analysis should be performed with minimum 10 g sample (1%). So 10 g is a minimum required range to execute a microbial limit test. • Some exceptional cases a lesser amount is prescribed, but need to be justified and authorized (e.g. clinical trials). ☆ Standardization: • For MLT, the results have encoded in "gram" or "mL" i.e. <10 CFU/g or <100 CFU/mL. • So at least the analysis must be executed with 10 g / 10 mL of the sample for a better microbial recovery and standard result. • 10 g is more sufficient for enumerating microorganisms and favorable for calculation. • This harmonized standard ensures consistency and comparability of results between different laboratories and regions. ☆ Method suitability: • In MLT method validation, Product Positive Control (PPC), Positive Control (PC) should meet their guideline requirement for microbial recovery. • Based on that, 10 g in 90 mL diluent sample preparation (1:10) or suspended sample preparation from 10 g (1:100) provides a wide range of microbial growth. ☆ Antimicrobial neutralization: • Whenever a high amount of sample is used for analysis (e.g. 20 g or 50 g), the antimicrobial property of raw material can inhibit the growth of microorganisms during validation. • Moreover, 1:10 (10 mL or 10 g in 90 mL) dilution has balanced the concentration of sample and antimicrobial properties for better microbial recovery.

Master Sample Preparation Guide by Product Type

Product Nature	Preparation Step-by-Step Method	Suitable Diluents / Reagents	Critical Process Controls
Water-Soluble Products	Dissolve or dilute 10 g or 10 mL of the product directly into the diluent to make a 1:10 dilution.	* Buffered NaCl-Peptone (pH 7.0) * Phosphate Buffer (pH 7.2) * Soybean-Casein Digest Broth (SCDBR)	* Target pH: 6.0 to 8.0. * Adjust pH only if necessary.
Nonfatty & Water-Insoluble Products	Suspend 10 g or 10 mL of the product in the diluent to make a 1:10 dilution.	* Same diluents as above. * Optional: Add 1 g/L of Polysorbate 80 for poorly wettable powders.	* Ensure uniform suspension before pipetting. * Target pH: 6.0 to 8.0.
Fatty / Oily Products	1. Dissolve sample in sterile filtered Isopropyl Myristate, OR mix with a minimal amount of sterile Polysorbate 80. 2. Heat gently if needed (max 40°C, exception 45°C). 3. Emulsify by adding pre-warmed diluent to achieve a 1:10 dilution.	* Isopropyl Myristate (filter-sterilized) * Sterile Polysorbate 80 (or other non-inhibitory surfactant) * Pre-warmed standard diluent	* Strict Temperature Cap: Never exceed 45°C. * Minimize heating time to prevent heat-killing microbes. * Maintain emulsion for serial dilutions.
Aerosols (Fluids/Solids)	Aseptically transfer either the entire contents or a specific number of metered doses from the containers into a sterile container or directly into a membrane filtration apparatus.	* Standard validated diluents as per product nature.	* Must be performed under strict aseptic conditions to avoid environmental contamination during venting/spraying.

Dilution Preparation Table for Microbial Limit Testing (MLT):

Target Dilution	Sample Weight / Volume	Required Diluent Volume	Total Mixture Volume	Dilution Factor for Calculation	Physical Preparation Method by Product Nature
1:10	10 g or 10 mL	90 mL	100 mL	× 10	Water-soluble/insoluble: Dissolve or suspend in validated diluent. Fatty/oily: Dissolve in sterile Isopropyl Myristate or mix with minimal sterile Polysorbate 80 (max 45°C), then add pre-warmed diluent to volume.
1:10	1 g or 1 mL	9 mL	10 mL	× 10	Same as above, scaled down for smaller or expensive samples.
1:50	10 g or 10 mL	490 mL	500 mL	× 50	For highly antimicrobial, preservative-containing, dense or viscous products where 1:10 dilution is insufficient to neutralize microbial inhibition.
1:50	1 g or 1 mL	49 mL	50 mL	× 50	Scaled-down quantities for inhibitory products with constrained batch sizes.
1:100	10 g or 10 mL	990 mL	1000 mL (1 L)	× 100	For high-bioburden raw materials (e.g., starches, plant gums, herbal sources) or strongly inhibitory substances needing maximum dilution for microorganism recovery.
1:100	1 g or 1 mL	99 mL	100 mL	× 100	Scaled-down version for smaller sample quantities.

Microbial Enumeration Tests (TAMC and TYMC) via Membrane Filtration.

MICROBIAL ENUMERATION BY MEMBRANE FILTRATION

1. Equipment and Environmental Controls

Environment: Perform all assembly and filtration steps under a certified Laminar Air Flow (LAF) workbench.
Pore Size: Membrane filters must have a nominal pore size less than or equal to 0.45 microns (um).
Apparatus: Use a sterile filtration unit designed to allow the transfer of the filter to the medium.

2. Step-by-Step Sample Filtration Workflow (Prepare two separate membrane filters per sample: one for TAMC, one for TYMC)

Assemble and Moisten: Place the sterile 0.45 um membrane filter on the holder of the filtration unit and moisten the membrane with a suitable diluent.
Pre-Wet: Pre-wet the membrane with 50 mL of the suitable Rinse fluid.
Sample Load: Transfer a suitable quantity of the sample prepared (preferably representing 1 g of the product, which is normally 10 mL, or less if large numbers of CFU are expected) to each of the two membrane filters. Filter immediately by applying a vacuum.
Rinse Cycle: Rinse the membrane filter with 5 x 100 mL of suitable diluent.

⚠️ Critical Limit: Do not exceed a washing cycle of five times 100 mL per filter even if the product possesses antimicrobial properties. After completion of method suitability, the number of rinses will vary based on the specific validation of the product.

3. Incubation Matrix

Total Aerobic Microbial Count (TAMC): Transfer the membrane filter to the surface of Soybean Casein Digest Agar (SCDA). Incubate the plates at 30 to 35 degrees C for Not Less Than (NLT) 5 days.
Total Combined Yeasts and Molds Count (TYMC): Transfer the membrane to the surface of Sabouraud Dextrose Agar (SDA). Incubate the plate at 20 to 25 degrees C for Not Less Than (NLT) 7 days.

4. Test Negative Control

Pre-wet the membrane with 50 mL of the Rinse fluid.
Filter about 100 mL of rinsing fluid through the membrane filter by applying a vacuum.
Rinse the membrane with 5 X 100 mL of the suitable rinse fluid.
Note: In case the pre-wetting and rinsing fluid are different, use them as such in the negative control so as to cover all the variables in the test system.
Transfer one membrane to Soybean Casein Digest Agar (incubate at 30 to 35 degrees C for NLT 5 days). Transfer the other membrane to Sabouraud Dextrose Agar (incubate at 20 to 25 degrees C for NLT 7 days).
🔴 Acceptance Criteria: Negative control plates must show zero growth. If growth occurs, the test is invalid and a deviation investigation must be opened.

fffff

MICROBIAL ENUMERATION BY POUR PLATE METHOD

1. General Test Requirements

Replication: Perform the plate-count method at least in duplicate (2 plates) for each specific medium.
Final Calculation: Use the mean (average) count of the duplicate plates to calculate your final results.
Environment: All pipetting, pouring, and mixing must be done under a certified LAF (Laminar Air Flow) or BSC (Biosafety Cabinet) unit.

2. Step-by-Step Pour Plate Workflow

For Total Aerobic Microbial Count (TAMC):

Sample Delivery: Transfer aseptically 1 mL of the pretreated sample to each of two empty sterile Petri dishes.
Media Addition: Pour about 20 to 25 mL of sterile Soybean Casein Digest Agar (SCDA) into each dish.
- ⚠️ Critical Temperature Limit: The molten agar must be maintained at Not More Than (NMT) 45 degrees C.
- Control Check: You must use an IR Gun to verify and measure the temperature of the medium before pouring.
Mixing: Gently swirl and mix the plates to ensure an equal distribution of the sample throughout the agar.
Solidification: Allow the plates to sit completely undisturbed under the LAF/BSC unit until the agar solidifies.

For Total Combined Yeasts and Molds Count (TYMC):

Sample Delivery: Transfer aseptically 1 mL of the pretreated sample to each of two empty sterile Petri dishes (9 cm diameter).
Media Addition: Pour about 20 to 25 mL of sterile Sabouraud Dextrose Agar (SDA) into each dish.
- ⚠️ Critical Temperature Limit: The molten agar must be maintained at Not More Than (NMT) 45 degrees C.
Mixing & Solidification: Gently swirl and mix the plates for an equal distribution of the sample, and allow them to fully solidify under the LAF/BSC unit.

3. Test Negative Control Protocol

SCDA Control: Pipette 1 mL of pure diluent into an empty sterile Petri dish and pour 20 to 25 mL of sterile Soybean Casein Digest Agar.
SDA Control: Pipette 1 mL of pure diluent into a separate empty sterile Petri dish and pour 20 to 25 mL of sterile Sabouraud Dextrose Agar.
Purpose: These blank control plates monitor the sterility of your diluent, media batches, and testing environment.

4. Incubation Matrix

Plate Type	Target Count	Incubation Temperature	Incubation Duration
SCDA Plates	TAMC	30 to 35 degrees C	Not Less Than (NLT) 5 days
SDA Plates	TYMC	20 to 25 degrees C	Not Less Than (NLT) 7 days

5. Interpretation of Results and Counting Rules

TAMC Determination: The TAMC value is the number of CFU found growing on the SCDA plates.
- 🔍 Cross-Over Rule: If fungal/mold colonies are detected growing on your SCDA plates, they must be counted and included as part of your TAMC total.
TYMC Determination: The TYMC value is the number of CFU found growing on the SDA plates.
- 🔍 Cross-Over Rule: If bacterial colonies are detected growing on your SDA plates, they must be counted and included as part of your TYMC total.
Bacterial Overgrowth Exception: If you expect the TYMC to fail or exceed the acceptance criteria purely due to heavy, unwanted bacterial background growth, you are permitted to use Sabouraud Dextrose Agar containing validated antibiotics.

6. Calculations

Count the colonies on the duplicate plates after the full incubation period.
Calculate the arithmetic mean (average) of the counts for each medium.
Multiply the mean count by your initial product dilution factor to calculate and report the final total number of CFU/g or CFU/mL.

hhhhh

10 mL of a 1:10 dilution = 1.0 g of raw product (Used in the Membrane Filtration method).

1 mL of a 1:10 dilution = 0.1 g of raw product (Used in this Pour Plate method).

MICROBIAL ENUMERATION BY SURFACE-SPREAD METHOD

1. General Test Requirements

Replication: Perform the surface-spread method at least in duplicate (minimum 2 plates) for each specific medium.
Final Calculation: Use the arithmetic mean (average) of the duplicate plates to calculate your final quantitative results.
Environment: All pouring, drying, pipetting, and spreading must be performed under a certified LAF (Laminar Air Flow) unit or BSC (Biosafety Cabinet).

Step-by-Step Surface-Spread Workflow

For Total Aerobic Microbial Count (TAMC):

Plate Preparation: Use pre-incubated/pre-prepared media plates, OR prepare fresh plates by adding 20 to 25 mL of Soybean-Casein Digest Agar (SCDA) at a temperature of not more than 45 degrees C to each Petri dish. Allow to completely solidify.
Drying Phase: Dry the solidified agar surfaces thoroughly inside the Laminar Air Flow Unit to ensure the liquid sample absorbs cleanly without running.
Inoculation & Spreading: Pipette a measured volume of not less than 0.1 mL of your prepared sample directly onto the agar surface. Using a sterile glass rod / sterile spreader, distribute the liquid evenly across the entire surface.
Incubation: Invert the dishes and incubate the plates in an inverted position at 30 to 35 degrees C for Not Less Than (NLT) 5 days.

For Total Combined Yeasts and Molds Count (TYMC):

Plate Preparation: Use pre-incubated/pre-prepared media plates, OR prepare fresh plates by adding 20 to 25 mL of Sabouraud Dextrose Agar (SDA) at a temperature of not more than 45 degrees C to each Petri dish. Allow to completely solidify.
Drying Phase: Dry the plates inside a Laminar Air Flow cabinet or an incubator.
Inoculation & Spreading: Pipette a measured volume of not less than 0.1 mL of your prepared sample directly onto the agar surface. Spread it evenly using a sterile glass rod.
Incubation: Invert the dishes and incubate the plates in an inverted position at 20 to 25 degrees C for Not Less Than (NLT) 7 days.

3. Test Negative Control Protocol

Procedure: Perform a negative control in parallel by substituting your test sample with the chosen pure diluent (e.g., pipetting 0.1 mL of pure diluent onto both an SCDA plate and an SDA plate).
Acceptance Criteria: There must be zero growth of microorganisms on these plates. Any colony growth renders the entire testing session invalid and requires a formal laboratory deviation investigation.

Understanding the Bench Math (0.1 mL Aliquot)

Since you are spreading 0.1 mL of a 1:10 dilution, you are putting less actual raw sample on the plate compared to the Pour Plate method.

Your initial 1:10 dilution contains 0.1 g of product per 1 mL of liquid.
By pipetting 0.1 mL of that liquid, you are placing exactly 0.01 g of your raw material onto the agar surface.

Calculation Factor Rule:

To scale your result back up to report in CFU/g or CFU/mL, you must multiply your average plate count by 100 (accounting for both the 1:10 dilution and the 0.1 mL aliquot volume fraction).

\text{Final CFU/g} = \text{Arithmetic Mean Colony Count} \times 100

\text{Final CFU/g} = \text{Arithmetic Mean Colony Count} \times 100

0.1 g or mL	0.01 g or mL	0.001 g or mL	Probable Number of Bacteria
+	+	+	More than $10^3$ CFU/g or mL
+	+	-	Less than $10^3$ and more than $10^2$ CFU/g or mL
+	-	-	Less than $10^2$ and more than 10 CFU/g or mL
-	-	-	Less than 10 CFU/g or mL

Author Description

Author Social Links

Full width home advertisement

Travel the world

Climb the mountains

Post Page Advertisement [Top]